-+ 0.00%
-+ 0.00%
-+ 0.00%

AlphaValue/Baader Europe Downgrades Genmab to Add, Trims PT

MT Newswires·08/20/2026 08:34:40
Listen to the news
08:34 AM EDT, 08/20/2026 (MT Newswires) -- AlphaValue/Baader Europe on Thursday lowered Danish biotechnology company Genmab (GMAB.CO) to add from buy and reduced its price target to 2,661 Danish kroner from 2,698 kroner. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)